These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29653541)

  • 1. Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial.
    Corica T; Nowak AK; Saunders CM; Bulsara MK; Taylor M; Williams NR; Keshtgar M; Joseph DJ; Vaidya JS
    Radiat Oncol; 2018 Apr; 13(1):68. PubMed ID: 29653541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial.
    Keshtgar MR; Williams NR; Bulsara M; Saunders C; Flyger H; Cardoso JS; Corica T; Bentzon N; Michalopoulos NV; Joseph DJ
    Breast Cancer Res Treat; 2013 Aug; 140(3):519-25. PubMed ID: 23877341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial.
    Corica T; Nowak AK; Saunders CM; Bulsara M; Taylor M; Vaidya JS; Baum M; Joseph DJ
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):55-64. PubMed ID: 27511847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial.
    Merie R; Browne L; Cardoso JS; Cardoso MJ; Chin Y; Clark C; Graham P; Szwajcer A; Hau E
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):819-825. PubMed ID: 28834326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
    BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
    Welzel G; Boch A; Sperk E; Hofmann F; Kraus-Tiefenbacher U; Gerhardt A; Suetterlin M; Wenz F
    Radiat Oncol; 2013 Jan; 8():9. PubMed ID: 23294485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger H; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Blanc-Onfroy ML; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McReady D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph D; Tobias JS
    Br J Cancer; 2021 Aug; 125(3):380-389. PubMed ID: 34035435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom.
    Vaidya A; Vaidya P; Both B; Brew-Graves C; Bulsara M; Vaidya JS
    BMJ Open; 2017 Aug; 7(8):e014944. PubMed ID: 28819067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer.
    Vaidya JS; Bulsara M; Saunders C; Flyger H; Tobias JS; Corica T; Massarut S; Wenz F; Pigorsch S; Alvarado M; Douek M; Eiermann W; Brew-Graves C; Williams N; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Baum M; Joseph D
    JAMA Oncol; 2020 Jul; 6(7):e200249. PubMed ID: 32239210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).
    Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Saunders C; Brew-Graves C; Potyka I; Morris S; Vaidya HJ; Williams NR; Baum M
    Health Technol Assess; 2016 Sep; 20(73):1-188. PubMed ID: 27689969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.
    Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Keshtgar M; Flyger HL; Massarut S; Alvarado M; Saunders C; Eiermann W; Metaxas M; Sperk E; Sütterlin M; Brown D; Esserman L; Roncadin M; Thompson A; Dewar JA; Holtveg HM; Pigorsch S; Falzon M; Harris E; Matthews A; Brew-Graves C; Potyka I; Corica T; Williams NR; Baum M;
    Lancet; 2014 Feb; 383(9917):603-13. PubMed ID: 24224997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
    Coombs NJ; Coombs JM; Vaidya UJ; Singer J; Bulsara M; Tobias JS; Wenz F; Joseph DJ; Brown DA; Rainsbury R; Davidson T; Adamson DJ; Massarut S; Morgan D; Potyka I; Corica T; Falzon M; Williams N; Baum M; Vaidya JS
    BMJ Open; 2016 May; 6(5):e010703. PubMed ID: 27160842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient preferences for adjuvant radiotherapy in early breast cancer are strongly influenced by treatment received through random assignment.
    Corica T; Saunders CM; Bulsara MK; Taylor M; Joseph DJ; Nowak AK
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12985. PubMed ID: 30637839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy.
    Elsberger B; Romsauerova A; Vinnicombe S; Whelehan P; Brown DC; Dewar JA; Thompson AM; Evans A
    Eur J Surg Oncol; 2014 Feb; 40(2):163-7. PubMed ID: 24332581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
    Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906.
    Nozaki M; Kagami Y; Takahashi M; Machida R; Sekino Y; Shibata T; Ito Y; Nishimura Y; Teshima T; Ushijima H; Nagata Y; Matsumoto Y; Akimoto T; Takahashi K; Murayama S; Uno T; Tsujino K; Hamamoto Y; Nakagawa K; Kodaira T; Hiraoka M;
    Breast Cancer; 2022 Nov; 29(6):1042-1049. PubMed ID: 35861936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation.
    Kolberg HC; Uhl V; Massarut S; Holmes D; Kolberg-Liedtke C; Kelly EW; Lövey G; Vaidya JS
    Anticancer Res; 2019 Aug; 39(8):4215-4218. PubMed ID: 31366508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal cosmetic outcome after planned IORT boost with low kV X-rays-monocentric results from the TARGIT BQR registry.
    Goerdt L; Poemsl J; Spaich S; Welzel G; Abo-Madyan Y; Ehmann M; Berlit S; Tuschy B; Sütterlin M; Wenz F; Sperk E
    Transl Cancer Res; 2023 Jul; 12(7):1715-1726. PubMed ID: 37588731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of the BCCT.core software in evaluation of breast cosmesis - A systematic review.
    Trakis S; Lord H; Graham P; Fernandez R
    J Med Imaging Radiat Oncol; 2021 Oct; 65(6):817-825. PubMed ID: 33973358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
    Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
    Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.